Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
<p>Proteomics: DE and Reactome of Cyt proteins</p>
-д хадгалсан:
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
-н: Andrés Elía (15055031)
Хэвлэсэн: (2025) -
Supplementary Table S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
-н: Andrés Elía (15055031)
Хэвлэсэн: (2025) -
Supplementary Table S7 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
-н: Andrés Elía (15055031)
Хэвлэсэн: (2025) -
Supplementary Table S8 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
-н: Andrés Elía (15055031)
Хэвлэсэн: (2025) -
Figure 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
-н: Nigel Bundred (15046233)
Хэвлэсэн: (2025)